FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:FME - DE0005785802 - Common Stock
40.34 EUR
-0.56 (-1.37%)
Taking everything into account, FME scores 5 out of 10 in our fundamental rating. FME was compared to 27 industry peers in the Health Care Providers & Services industry. FME has an average financial health and profitability rating. FME has a decent growth rate and is not valued too expensively. FME also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
FME had positive earnings in the past year.
FME had a positive operating cash flow in the past year.
FME had positive earnings in each of the past 5 years.
FME had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
FME has a Return On Assets (2.33%) which is in line with its industry peers.
FME has a Return On Equity of 5.55%. This is in the lower half of the industry: FME underperforms 66.67% of its industry peers.
FME has a Return On Invested Capital of 3.95%. This is in the lower half of the industry: FME underperforms 62.96% of its industry peers.
FME had an Average Return On Invested Capital over the past 3 years of 3.14%. This is below the industry average of 6.98%.
The 3 year average ROIC (3.14%) for FME is below the current ROIC(3.95%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
FME has a Profit Margin (3.66%) which is in line with its industry peers.
FME's Profit Margin has declined in the last couple of years.
FME has a Operating Margin of 7.19%. This is comparable to the rest of the industry: FME outperforms 55.56% of its industry peers.
In the last couple of years the Operating Margin of FME has declined.
FME has a Gross Margin of 25.00%. This is comparable to the rest of the industry: FME outperforms 59.26% of its industry peers.
In the last couple of years the Gross Margin of FME has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FME is destroying value.
FME has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for FME has been reduced compared to 5 years ago.
FME has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.21 indicates that FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
FME's Altman-Z score of 2.21 is in line compared to the rest of the industry. FME outperforms 55.56% of its industry peers.
FME has a debt to FCF ratio of 5.97. This is a neutral value as FME would need 5.97 years to pay back of all of its debts.
The Debt to FCF ratio of FME (5.97) is better than 70.37% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that FME is somewhat dependend on debt financing.
The Debt to Equity ratio of FME (0.73) is better than 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 2.21 |
ROIC/WACC0.7
WACC5.66%
2.3 Liquidity
A Current Ratio of 1.36 indicates that FME should not have too much problems paying its short term obligations.
The Current ratio of FME (1.36) is better than 66.67% of its industry peers.
FME has a Quick Ratio of 1.36. This is a bad value and indicates that FME is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of FME (1.00) is better than 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.77% over the past year.
FME shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.43% yearly.
FME shows a small growth in Revenue. In the last year, the Revenue has grown by 2.10%.
The Revenue has been growing slightly by 2.04% on average over the past years.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
FME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.73% yearly.
The Revenue is expected to grow by 4.08% on average over the next years.
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.73%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y4.08%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
FME is valuated reasonably with a Price/Earnings ratio of 10.73.
FME's Price/Earnings ratio is rather cheap when compared to the industry. FME is cheaper than 88.89% of the companies in the same industry.
FME is valuated cheaply when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 9.74 indicates a reasonable valuation of FME.
Based on the Price/Forward Earnings ratio, FME is valued cheaper than 81.48% of the companies in the same industry.
FME is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.22, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.73 | ||
| Fwd PE | 9.74 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FME is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FME is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.49 | ||
| EV/EBITDA | 10.62 |
4.3 Compensation for Growth
FME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FME's earnings are expected to grow with 13.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y12.9%
EPS Next 3Y13.44%
5. Dividend
5.1 Amount
FME has a Yearly Dividend Yield of 3.50%.
FME's Dividend Yield is rather good when compared to the industry average which is at 2.04. FME pays more dividend than 100.00% of the companies in the same industry.
FME's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
5.2 History
The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
58.83% of the earnings are spent on dividend by FME. This is a bit on the high side, but may be sustainable.
FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.83%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
FRA:FME (12/3/2025, 5:36:15 PM)
40.34
-0.56 (-1.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.67B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts65.6
Price Target48.43 (20.05%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-3.8%
PT rev (3m)-4.91%
EPS NQ rev (1m)-1.78%
EPS NQ rev (3m)-4.91%
EPS NY rev (1m)0.52%
EPS NY rev (3m)0.42%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.73 | ||
| Fwd PE | 9.74 | ||
| P/S | 1.21 | ||
| P/FCF | 13.49 | ||
| P/OCF | 9.43 | ||
| P/B | 1.83 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.62 |
EPS(TTM)3.76
EY9.32%
EPS(NY)4.14
Fwd EY10.27%
FCF(TTM)2.99
FCFY7.41%
OCF(TTM)4.28
OCFY10.61%
SpS33.47
BVpS22.07
TBVpS-3.21
PEG (NY)0.58
PEG (5Y)N/A
Graham Number43.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.21 |
F-Score5
WACC5.66%
ROIC/WACC0.7
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.73%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y4.08%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.66%
EBIT Next 3Y30.5%
EBIT Next 5Y18.68%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Fairly Valued.
What is the profitability of FME stock?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for FME stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 10.73 and the Price/Book (PB) ratio is 1.83.
Can you provide the dividend sustainability for FME stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 58.83%.